BMP-9 Modulates the Hepatic Responses to LPS.

Area of Science:

• Hepatology
• Immunology
• Molecular Biology

Background:

• Bone Morphogenetic Protein (BMP)-9 is produced by hepatic stellate cells and implicated in liver fibrogenesis.
• Lipopolysaccharide (LPS) is a key factor in liver disease pathogenesis.
• The interaction between BMP-9 and LPS in liver injury is not fully understood.

Purpose of the Study:

• To investigate the role of high BMP-9 levels in conjunction with LPS signaling in enhancing liver damage.
• To elucidate the mechanisms by which LPS influences BMP-9 expression and function in the liver.

Main Methods:

• Stimulation of human liver sinusoidal endothelial cells (LSEC) with LPS.
• Incubation of primary human liver myofibroblasts (MF) with conditioned LSEC medium.
• Analysis of BMP-9 expression, inflammatory cytokine induction, and signaling pathways (Nfkb, Smad-1) in vitro.
• In vivo studies in mice to assess hepatic cellular responses and inflammatory mediator regulation.

Main Results:

• LPS stimulation of LSEC induced the secretion of factors, including IL-6, that upregulate BMP-9 expression in MF.
• High BMP-9, particularly with LPS, promoted capillarization markers in LSEC and enhanced pro-inflammatory cytokine production in macrophages.
• BMP-9 modulated LPS-mediated signaling pathways differently in LSEC and macrophages.
• In vivo, BMP-9 influenced F4/80-positive cell presence and inflammatory mediator regulation in the liver.

Conclusions:

• BMP-9 acts as a complex modulator of hepatic responses to LPS.
• Initial LPS effects upregulate BMP-9, but sustained high levels promote pro-inflammatory macrophage reactions.
• Precise spatial and temporal regulation of BMP-9 is essential for effective liver wound healing.